Patient Capital Management, LLC

CIK 0001854794 · BALTIMORE, MD · Quarter end: 2026-06-30 · Filed on: 2026-08-13 · Open the SEC source

Patient Capital Management, LLC reported 40 positions worth $3.05B as of June 30, 2026 (13F filed August 13, 2026). Largest holding: RPRX (6.6%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$3.05B
2026 Q2
Positions
40
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
51.4%
Est. Net Flow (Q)
2026 Q2
10 / 40 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1RPRXROYALTY PHARMA PLCSH$201.8M6.61%3,598,808
2CCITIGROUP INCSH$196.4M6.44%1,403,477
3GOOGLALPHABET INCSH$187.9M6.16%525,750
4UNHUNITEDHEALTH GROUP INCSH$182.0M5.96%437,773
5AMZNAMAZON COM INCSH$162.3M5.32%681,047
6NVDANVIDIA CORPORATIONSH$142.0M4.65%709,587
7CVSCVS HEALTH CORPSH$127.8M4.19%1,235,505
8NCLHNORWEGIAN CRUISE LINE HLDGSSH$127.3M4.17%6,029,642
9QXOQXO INCSH$123.3M4.04%7,136,669
10ETENERGY TRANSFER L PSH$116.3M3.81%6,080,678

The free plan shows the top 10 positions. The remaining 30 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Patient Capital Management, LLC hold as of Q2 2026?

Patient Capital Management, LLC reported 40 positions worth $3.05B in its Q2 2026 13F filing. Largest positions: RPRX (6.6%), C (6.4%), GOOGL (6.2%), UNH (6.0%) and AMZN (5.3%).

What did Patient Capital Management, LLC buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Patient Capital Management, LLC sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.